Medicine and Dentistry
Epidermolysis Bullosa Dystrophica
100%
Epidermolysis bullosa
85%
Pruritus
73%
Wound Healing
37%
Prevalence
37%
Clinical Trial
34%
Cohort Effect
32%
Pathophysiology
32%
Transcriptomics
32%
ABCB5
32%
Drug Repositioning
32%
Mesenchymal Stem Cell
32%
Wound
19%
Collagen Type 7
11%
Diseases
11%
Quality of Life
9%
Dermatosis
8%
Lymphadenopathy
8%
Numeric Rating Scale
8%
Allergic Response
8%
Scar Formation
8%
Disease Activity
8%
Clinician
8%
Adverse Event
8%
Disease Modifying Therapy
8%
Arm
8%
Sequela
8%
Tissue Repair
8%
Intravenous Drug Administration
8%
Skin Fragility
8%
Lifespan
8%
Gene Expression Profiling
6%
Cytokine
6%
Skin Injury
5%
Sensory Nerve Ending
5%
Dermatitis
5%
Dermoepidermal Junction
5%
National Health Service
5%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermolysis Bullosa Dystrophica
64%
Epidermolysis bullosa
48%
Pruritus
40%
Wound Healing
37%
Drug Repositioning
32%
Pathophysiology
32%
Clinical Trial
32%
Prevalence
32%
Diseases
22%
Wound
19%
Collagen Type 7
11%
Skin Disease
8%
Tissue Repair
8%
Inflammation
8%
Skin Fragility
8%
Adverse Event
8%
Lymphadenopathy
8%
Tolerability
8%
Allergic Reaction
8%
Mouse Model
8%
Disease Activity
8%
Scar Formation
8%
Cytokine
6%
Dermatitis
5%
Skin Injury
5%
